Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017

J Gen Intern Med. 2019 Apr;34(4):518-520. doi: 10.1007/s11606-018-4752-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Analgesics, Opioid / therapeutic use*
  • Benzodiazepines / therapeutic use
  • Formularies as Topic*
  • Gabapentin / therapeutic use
  • Humans
  • Hypnotics and Sedatives / therapeutic use
  • Insurance Coverage / statistics & numerical data*
  • Medicare Part D*
  • United States

Substances

  • Analgesics, Opioid
  • Hypnotics and Sedatives
  • Benzodiazepines
  • Gabapentin